Ro et al., 2007 - Google Patents
Adipocyte enhancer‐binding protein 1 modulates adiposity and energy homeostasisRo et al., 2007
View PDF- Document ID
- 10369082194808118712
- Author
- Ro H
- Zhang L
- Majdalawieh A
- Kim S
- Wu X
- Lyons P
- Webber C
- Ma H
- Reidy S
- Boudreau A
- Miller J
- Mitchell P
- McLeod R
- Publication year
- Publication venue
- Obesity
External Links
Snippet
Objective: To determine whether adipocyte enhancer binding protein (AEBP) 1, a transcriptional repressor that is down‐regulated during adipogenesis, functions as a critical regulator of adipose tissue homeostasis through modulation of phosphatase and tensin …
- 101700086443 AEBP1 0 title abstract description 249
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ro et al. | Adipocyte enhancer‐binding protein 1 modulates adiposity and energy homeostasis | |
| Nakae et al. | Forkhead transcription factor FoxO1 in adipose tissue regulates energy storage and expenditure | |
| Huang et al. | Molecular characterization of the role of orphan receptor small heterodimer partner in development of fatty liver | |
| Kubota et al. | PPARγ mediates high-fat diet–induced adipocyte hypertrophy and insulin resistance | |
| Akiyama et al. | Conditional disruption of the peroxisome proliferator-activated receptor γ gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol efflux | |
| Rached et al. | FoxO1 expression in osteoblasts regulates glucose homeostasis through regulation of osteocalcin in mice | |
| Cederberg et al. | FOXC2 is a winged helix gene that counteracts obesity, hypertriglyceridemia, and diet-induced insulin resistance | |
| Chen et al. | Farnesoid X receptor alleviates age‐related proliferation defects in regenerating mouse livers by activating forkhead box m1b transcription | |
| Soriano et al. | Evidence for a mitochondrial regulatory pathway defined by peroxisome proliferator–activated receptor-γ coactivator-1α, estrogen-related receptor-α, and mitofusin 2 | |
| Tsai et al. | Hypertension and abnormal fat distribution but not insulin resistance in mice with P465L PPARγ | |
| Nakae et al. | The forkhead transcription factor Foxo1 regulates adipocyte differentiation | |
| Miki et al. | Essential role of insulin receptor substrate 1 (IRS-1) and IRS-2 in adipocyte differentiation | |
| Pontoglio et al. | Hepatocyte nuclear factor 1 inactivation results in hepatic dysfunction, phenylketonuria, and renal Fanconi syndrome | |
| Hu et al. | Isoform-specific functions of PPARγ in gene regulation and metabolism | |
| Cernkovich et al. | Adipose-specific disruption of signal transducer and activator of transcription 3 increases body weight and adiposity | |
| Su et al. | The ABCG5 ABCG8 sterol transporter opposes the development of fatty liver disease and loss of glycemic control independently of phytosterol accumulation | |
| Izumi et al. | CRISPR/Cas9-mediated Angptl8 knockout suppresses plasma triglyceride concentrations and adiposity in rats | |
| Mesli et al. | Distribution of the lipolysis stimulated receptor in adult and embryonic murine tissues and lethality of LSR–/–embryos at 12.5 to 14.5 days of gestation | |
| US20060035849A1 (en) | Methods and composition for modulating type I muscle formation using pgc-1 alpha | |
| Zhang et al. | The role of AEBP1 in sex-specific diet-induced obesity | |
| Lu et al. | QKI regulates adipose tissue metabolism by acting as a brake on thermogenesis and promoting obesity | |
| Guo et al. | AAV‐mediated nuclear localized PGC1α4 delivery in muscle ameliorates sarcopenia and aging‐associated metabolic dysfunctions | |
| Yoshiga et al. | Adaptor protein SH2-B linking receptor-tyrosine kinase and Akt promotes adipocyte differentiation by regulating peroxisome proliferator-activated receptor γ messenger ribonucleic acid levels | |
| Memon et al. | Upregulation of uncoupling protein 2 mRNA in genetic obesity: lack of an essential role for leptin, hyperphagia, increased tissue lipid content, and TNF-α | |
| Han et al. | AUTHOR COPY ONLY |